Owners, management and financials
CVR: 34202982
Secondary names: Biocare CPH A/S, Nordic Biohealth A/S, Biohealth Nordic A/S
Previous names: BIOCARE COPENHAGEN ApS
DKK 42,330,000
Gross profit
Net result: DKK 30,571,000
DSM International B.V. (100%)
CVR · view owners
Tamás Kecskés, Nicolas Claude Jacques Touillon
Board: Kristina Tahiri (chair) and 2 members
CVR · view management
Active
Founded 3 January 2012
CVR · view overview
4 employees
CVR · 2026
Director role ended: Ole Lund Svendsen
CVR · 16/12/2025
View the full event history
BIOCARE COPENHAGEN A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 2012. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named BIOCARE COPENHAGEN ApS. The management consists of Tamás Kecskés and Nicolas Claude Jacques Touillon. The board consists of Kristina Tahiri (chair), Edyta Strojna and Kjeld Raunkjær Kjeldsen. The company is owned by DSM International B.V.. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 42,330,000 and a net result of DKK 30,571,000 compared with DKK 24,704,000 the year before. Equity in the 2025 report amounted to DKK 41,846,000.
Source: annual report 2025, Danish Business Authority
The financial health of BIOCARE COPENHAGEN A/S appears robust, with a consistent upward trend in gross profit and profit over the past few years. Gross profit increased from 23.7 million DKK in 2023 to 42.3 million DKK in 2025, while profit rose from 14.6 million DKK to 30.6 million DKK in the same period, indicating strong operational efficiency and profitability. The company's equity has also improved significantly, reaching 41.8 million DKK in 2025, which suggests a solid financial foundation. However, the lack of disclosed revenue figures may raise concerns regarding transparency and market position within the specialized goods agency sector. Overall, BIOCARE COPENHAGEN A/S is positioned favorably, with strong margins and growing profitability, although further clarity on revenue would enhance its financial profile.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at udvikle og kommercialisere kosttilskud samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 42.3 mio. | 30.6 mio. | 117.1 mio. | 41.8 mio. | 4 | |
| 202401/01/2024 – 31/12/2024 | 35.5 mio. | 24.7 mio. | 57.8 mio. | 26.3 mio. | 4 | |
| 202301/01/2023 – 31/12/2023 | 23.7 mio. | 14.6 mio. | 40.9 mio. | 15.6 mio. | 5 | |
| 202201/01/2022 – 31/12/2022 | 24.4 mio. | 14.5 mio. | 46.4 mio. | 15.9 mio. | 6 | |
| 202101/01/2021 – 31/12/2021 | 28.3 mio. | 17.1 mio. | 49.7 mio. | 29.4 mio. | 6 | |
| 202001/01/2020 – 31/12/2020 | 31.7 mio. | 18 mio. | 55.3 mio. | 35.3 mio. | 5 | |
| 201901/01/2019 – 31/12/2019 | 25.8 mio. | 14.6 mio. | 68.1 mio. | 47.4 mio. | 5 | |
| 201801/01/2018 – 31/12/2018 | 25.8 mio. | 15.3 mio. | 50.7 mio. | 32.8 mio. | 6 | |
| 201701/01/2017 – 31/12/2017 | 23.8 mio. | 13.8 mio. | 36.2 mio. | 17.4 mio. | 10 | |
| 201601/01/2016 – 31/12/2016 | 10.3 mio. | 4.3 mio. | 10.1 mio. | 4.7 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 9.5 mio. | 4.2 mio. | 12.6 mio. | 1.5 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 7.9 mio. | 2 mio. | 12.1 mio. | 3.2 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 6.5 mio. | 1.4 mio. | 9.8 mio. | 1.2 mio. | - | |
| 201203/01/2012 – 31/12/2012 | 1.7 mio. | -279 t. | 9.3 mio. | -199 t. | - |
Compared to 159 companies in Agenturhandel med specialiseret varesortiment, bortset fra køretøjer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of BIOCARE COPENHAGEN A/S is 34202982.
BIOCARE COPENHAGEN A/S is owned by DSM International B.V..
The management of BIOCARE COPENHAGEN A/S consists of Tamás Kecskés and Nicolas Claude Jacques Touillon.
The board of BIOCARE COPENHAGEN A/S consists of Kristina Tahiri, Edyta Strojna and Kjeld Raunkjær Kjeldsen, with Kristina Tahiri as chair.
In 2025, BIOCARE COPENHAGEN A/S reported a gross profit of DKK 42,330,000.
BIOCARE COPENHAGEN A/S had 4 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
BIOCARE COPENHAGEN A/S has published its annual report for 2025. Gross profit came to DKK 42,330,000, and the net result was DKK 30,571,000.
Contact info changed: new phone: 70200506, new website: www.biocarecph.com (January 14, 2026).
As of December 16, 2025, Kjeld Raunkjær Kjeldsen has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of December 16, 2025, Kristina Tahiri has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of December 16, 2025, Ole Lund Svendsen has left the board of directors of BIOCARE COPENHAGEN A/S.
As of December 16, 2025, Nicolas Claude Jacques Touillon is registered as director of BIOCARE COPENHAGEN A/S.
As of December 16, 2025, Ole Lund Svendsen has stepped down as director of BIOCARE COPENHAGEN A/S.
As of December 15, 2025, Kristina Tahiri has left the board of directors of BIOCARE COPENHAGEN A/S.
As of November 7, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BIOCARE COPENHAGEN A/S.
As of November 7, 2025, KPMG P/S has stepped down as auditor of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2024. Gross profit came to DKK 35,451,000, and the net result was DKK 24,704,000.
BIOCARE COPENHAGEN A/S has published its annual report for 2023. Gross profit came to DKK 23,720,000, and the net result was DKK 14,628,000.
As of November 30, 2023, Edyta Strojna has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of November 30, 2023, James Young has left the board of directors of BIOCARE COPENHAGEN A/S.
As of November 30, 2023, Tamás Kecskés is registered as adm. dir. of BIOCARE COPENHAGEN A/S.
As of November 30, 2023, Tomasz Sikora has stepped down as adm. dir. of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2022. Gross profit came to DKK 24,430,000, and the net result was DKK 14,514,000.
As of April 19, 2023, Ole Lund Svendsen is registered as director of BIOCARE COPENHAGEN A/S.
As of April 19, 2023, Jens Wilhelm Kück has stepped down as director of BIOCARE COPENHAGEN A/S.
As of March 20, 2023, Kristina Tahiri has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of March 20, 2023, Maha Mazhar Ali Abdelhamid Elkharbotly has left the board of directors of BIOCARE COPENHAGEN A/S.
As of March 20, 2023, Tomasz Sikora is registered as adm. dir. of BIOCARE COPENHAGEN A/S.
As of March 20, 2023, Antonio Fernando Almeida de Carvalho has stepped down as adm. dir. of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2021. Gross profit came to DKK 28,310,000, and the net result was DKK 17,092,000.
As of March 8, 2022, James Young has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of March 8, 2022, Hemant Narasimhan has left the board of directors of BIOCARE COPENHAGEN A/S.
As of March 8, 2022, Jens Wilhelm Kück is registered as director of BIOCARE COPENHAGEN A/S.
As of March 8, 2022, Antonio Fernando Almeida de Carvalho is registered as adm. dir. of BIOCARE COPENHAGEN A/S.
As of March 8, 2022, Daniele Reale has stepped down as director of BIOCARE COPENHAGEN A/S.
As of March 7, 2022, Jens Wilhelm Kück has stepped down as adm. dir. of BIOCARE COPENHAGEN A/S.
As of October 7, 2021, KPMG P/S has been appointed auditor of BIOCARE COPENHAGEN A/S.
As of October 7, 2021, EY Godkendt Revisionspartnerselskab has stepped down as auditor of BIOCARE COPENHAGEN A/S.
As of October 7, 2021, Ole Lund Svendsen has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of October 7, 2021, Hemant Narasimhan has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of October 7, 2021, Zulfija Madzitova has left the board of directors of BIOCARE COPENHAGEN A/S.
As of October 7, 2021, Floor Saris has left the board of directors of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2020. Gross profit came to DKK 31,681,750, and the net result was DKK 17,978,255.
As of July 1, 2021, Jens Wilhelm Kück is registered as adm. dir. of BIOCARE COPENHAGEN A/S.
As of July 1, 2021, Daniele Reale is registered as director of BIOCARE COPENHAGEN A/S.
As of July 1, 2021, Søren Baungaard Thomsen has stepped down as adm. dir. of BIOCARE COPENHAGEN A/S.
As of June 30, 2021, Jens Wilhelm Kück has stepped down as director of BIOCARE COPENHAGEN A/S.
As of December 22, 2020, Jens Wilhelm Kück is registered as director of BIOCARE COPENHAGEN A/S.
As of December 22, 2020, Jesper Neergaard Gantzel has stepped down as director of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2019. Gross profit came to DKK 25,763,075, and the net result was DKK 14,597,164.
As of July 6, 2020, Maha Mazhar Ali Abdelhamid Elkharbotly has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of July 6, 2020, Floor Saris has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of July 6, 2020, Jinghuai Xu has left the board of directors of BIOCARE COPENHAGEN A/S.
As of July 5, 2020, Maha Mazhar Ali Abdelhamid Elkharbotly has left the board of directors of BIOCARE COPENHAGEN A/S.
As of January 7, 2020, Maha Mazhar Ali Abdelhamid Elkharbotly has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of January 7, 2020, Wesley Amberg Parris has left the board of directors of BIOCARE COPENHAGEN A/S.
As of June 11, 2019, Zulfija Madzitova has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of June 11, 2019, Ivo Constantijn Lansbergen has left the board of directors of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2018. Gross profit came to DKK 25,829,559, and the net result was DKK 15,335,805.
As of February 4, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of BIOCARE COPENHAGEN A/S.
As of February 4, 2019, Din Revisor Lyngby A/S Godkendte Revisorer has stepped down as auditor of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2017. Gross profit came to DKK 23,771,428, and the net result was DKK 13,774,365.
As of December 21, 2017, Jinghuai Xu has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of December 21, 2017, Wesley Amberg Parris has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of December 21, 2017, Ivo Constantijn Lansbergen has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of December 21, 2017, Ole Nørgaard has left the board of directors of BIOCARE COPENHAGEN A/S.
As of December 21, 2017, Thor Jespersen has left the board of directors of BIOCARE COPENHAGEN A/S.
As of December 21, 2017, Erik Kromann has left the board of directors of BIOCARE COPENHAGEN A/S.
As of December 21, 2017, is registered as an owner of BIOCARE COPENHAGEN A/S with an ownership share of 100%.
BIOCARE COPENHAGEN A/S has published its annual report for 2016. Gross profit came to DKK 10,260,208, and the net result was DKK 4,276,072.
BIOCARE COPENHAGEN A/S has published its annual report for 2015. Gross profit came to DKK 9,497,568, and the net result was DKK 4,238,215.
As of August 17, 2015, Thor Jespersen has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of August 17, 2015, Erik Kromann has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of August 16, 2015, Thor Jespersen has left the board of directors of BIOCARE COPENHAGEN A/S.
As of August 16, 2015, Erik Kromann has left the board of directors of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2014. Gross profit came to DKK 7,935,065, and the net result was DKK 2,028,274.
On January 1, 2015, the company changed its name from BIOCARE COPENHAGEN ApS to BIOCARE COPENHAGEN A/S.
As of September 18, 2014, Din Revisor Lyngby A/S Godkendte Revisorer has been appointed auditor of BIOCARE COPENHAGEN A/S.
As of September 18, 2014, A/S PSE 17 NR. 1056 has stepped down as auditor of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S has published its annual report for 2013. Gross profit came to DKK 6,464,324, and the net result was DKK 1,404,772.
BIOCARE COPENHAGEN A/S has published its annual report for 2012. Gross profit came to DKK 1,691,696, and the net result was DKK -279,034.
As of January 3, 2012, A/S PSE 17 NR. 1056 has been appointed auditor of BIOCARE COPENHAGEN A/S.
As of January 3, 2012, Ole Nørgaard has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of January 3, 2012, Thor Jespersen has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of January 3, 2012, Erik Kromann has joined the board of directors of BIOCARE COPENHAGEN A/S.
As of January 3, 2012, Jesper Neergaard Gantzel is registered as director of BIOCARE COPENHAGEN A/S.
As of January 3, 2012, Søren Baungaard Thomsen is registered as adm. dir. of BIOCARE COPENHAGEN A/S.
BIOCARE COPENHAGEN A/S was founded on January 3, 2012.
Companies in the same industry and area
CVR 43885294
CVR 70515113
CVR 29241260
CVR 63557218
CVR 44796813
